Sign inJoin waitlistJoin the waitlist

Robert Molokie

Director of Student Engagement · University of Illinois College of Medicine at Chicago

Credentials: · · ·

History

Hematology and Medical Oncology
1989–1992
Loyola University Medical Center
1986–1989
John H. Stroger Jr. Hospital of Cook County
1983–1986
University of Illinois College of Medicine
1979–1983

Research

Effects of 5-aza-2'-deoxycytidine on fetal hemoglobin levels, red cell adhesion, and hematopoietic differentiation in patients with sickle cell disease
Blood · 2003 · 216 citations
Patient-reported outcomes: descriptors of nociceptive and neuropathic pain and barriers to effective pain management in adult outpatients with sickle cell disease
Journal of the National Medical Association · 2010 · 159 citations
2-deoxy 5-azacytidine and fetal hemoglobin induction in sickle cell anemia
Blood · 2000 · 140 citations

Victor Gordeuk
36 papers
Santosh Saraf
35 papers · 1 as a fellow
MG
Michel Gowhari
26 papers · 1 as a fellow
Judith Schlaeger
17 papers
Shivi Jain
12 papers
JH
Johara Hassan
11 papers · 10 as a fellow
Angela Rivers
8 papers
Franklin Njoku
8 papers
Lewis Hsu
7 papers
Roberto Machado
7 papers
Yogen Saunthararajah
7 papers
Alexis Thompson
6 papers

Grants

Exploring the Mediterranean Diet as A Promising Approach for Alleviating Chronic Pain in Sickle Cell Disease
National Center for Complementary and Integrative Health · R21
PI · $437.5K · University of Illinois at Chicago
2025–2027
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain
National Center for Complementary and Integrative Health · UH3
PI · $6.4M · University of Illinois at Chicago
2020–2026
Hybrid Effectiveness-Implementation Trial of Guided Relaxation and Acupuncture for Chronic Sickle Cell Disease Pain
National Center for Complementary and Integrative Health · UG3
PI · $827.2K · University of Illinois at Chicago
2020–2021
HL-Phenotypic Characterization of Chronic Pain in Adults with Sickle Cell Disease
National Heart, Lung, and Blood Institute · R01
Contact PI · $3.2M · University of Illinois at Chicago
2014–2019

Clinical trials

A Study of Nicotinamide With Oral Tetrahydrouridine and Decitabine to Treat High Risk Sickle Cell Disease
Principal investigator · Recruiting · Phase 1
EpiDestiny, Inc.
2020–2027